Advertisement
UK markets closed

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     

  • AIM

    789.87
    +6.17 (+0.79%)
     

  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     

  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     

  • Bitcoin GBP

    48,547.63
    -1,900.28 (-3.77%)
     

  • CMC Crypto 200

    1,257.32
    -100.69 (-7.41%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • DOW

    39,512.84
    +125.08 (+0.32%)
     

  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     

  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     

  • DAX

    18,772.85
    +86.25 (+0.46%)
     

  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     
MONEY:

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

Allergan CEO resigns from Edwards Lifesciences' board

Reuters - UK Focus

Oct 3 (Reuters) - Edwards Lifesciences Corp (NYSE: EW - news) said David Pyott resigned from the medical device maker's board to devote more time to his role as chairman and CEO of Allergan Inc (NYSE: AGN - news) .

The resignation of Pyott, who joined Edwards' board in 2000, is effective immediately, the company said in a statement.

Allergan is fighting a $53.7-billion hostile bid from Canada's Valeant Pharmaceuticals International Inc (NYSE: VRX - news) and billionaire William Ackman's Pershing Square.

Edwards Lifesciences shares closed at $106.18 Friday on the New York Stock Exchange. (Reporting by Shailesh Kuber in Bangalore; Editing by Anil D'Silva)